Affidea

We are pleased to announce that Guy Blomfield, Group CEO and Chairman of the Management Board of Affidea, will speak at the 2nd edition of the in Private Capital , organised in association with the European Healthcare Investor Association (E.H.I.A.)

As part of a dedicated case-study session, Guy will share Affidea’s experience in building an integrated model of Out-of-Hospital, community-based , exploring the strategies, outcomes and lessons learned from its real-world implementation in 420 clinics across 15 countries in Europe.

The presentation will also offer insights into the market trends shaping the , followed by an interactive Q&A with participants, moderated by Ian Poburenny, Director at Rothschild.

We look forward to contributing to an important conversation about how innovation and new models of can help create more , and healthcare, delivered closer to the communities and patients we serve. 💙

📅 16 June 2026
📍 Institute of Directors, London
▶️ More information about the conference: https://lnkd.in/eRJie4fC

With: Henry Elphick, Ian Poburenny, Guy Blomfield

We are proud to share that a multidisciplinary team of Affidea radiation oncologists, medical physicists and radiation therapy technologists participated in , Europe’s leading congress in radiation oncology.

For Affidea, participation in leading scientific forums such as ESTRO is an important part of how we continue to strengthen clinical expertise, exchange knowledge, and advance the quality and consistency of cancer care across our network.

“ is a critical pillar of modern cancer care, where clinical expertise, innovation, precision and multidisciplinary collaboration must come together to deliver the best possible outcomes for patients. At Affidea, our role as a pan-European healthcare provider is not only to invest in advanced technologies, but to ensure that they are embedded within strong clinical , assurance and continuous professional development. By connecting expertise across countries and disciplines, we can accelerate learning, support innovation, and strengthen the safety and personalisation of cancer treatment. This is how we continue to raise standards in care across our network — with patients at the centre of every decision.” — Alessandro Roncacci, SVP Chief Medical Officer, Affidea Group.

“Quality in radiation is not only about technology, it is about combining human expertise, scientific knowledge, technical precision and collaboration to deliver the best possible for every individual patient. By working together across an international network like Affidea, specialists can share knowledge, optimise treatments, advance quality assurance and integrate innovative tools such as to strengthen precision in patient care. Combining expertise, technology, manpower and infrastructure allows us to continuously improve outcomes and the overall patient journey, because true quality is built through collaboration.” — Philip Poortmans, Medical Advisor Radiation Oncology, Affidea Group